TB Alliance Case Study on Expanding Access to Life-Saving Tuberculosis Treatments Published by INSEAD
MBA students tackle one of global health’s toughest challenges – how to reduce drug rollout timelines to just one year
Access News
Academic Study Finds TB Alliance’s Access Approach Successfully Accelerated Uptake of New TB Treatments
Findings underscore critical role of product development partnerships in delivering both innovation and access GENEVA (April 24, 2026)—A new peer-reviewed
New Report: LIFT-TB Helped Cut Time to Global Uptake of Improved Drug-Resistant TB Treatments from Nearly a Decade to Three Years
Country-led evidence and implementation support enabled faster adoption of shorter, more effective regimens worldwide SEOUL (April 13, 2026)—A new independent
TB Alliance and Asian Development Bank Forge Strategic Partnership to Strengthen Regional Efforts Against Tuberculosis
New York, USA and Manila, Philippines — [Date] — TB Alliance and the Asian Development Bank (ADB) have announced a
Digital First, Faster Access: How TB Alliance Is Using Tech to Speed BPaL/M to People Who Need It
For decades, breakthrough TB science has too often moved slowly from approval to those in need. In the roll out
TB Alliance Launches Upskill TB Platform in Collaboration with Indonesia’s Ministry of Health and RPRI Foundation
Digital Training Platform, Upskill TB, Strengthens Capacity to Deliver New DR-TB Treatments JAKARTA (October 9, 2025)—TB Alliance, in collaboration with
DR-TB Regimen Will Save 190,000+ Additional Lives and $1.29B by 2035
The six-month, all-oral BPaL/M regimens for the treatment of drug-resistant TB (DR-TB) are already changing the trajectory of DR-TB care
New Study Finds Investing in Shorter, More Effective TB Treatment Pays Off
A new analysis, published in IJTLD Open, from South Africa and the Philippines further confirms that six-month, all-oral BPaL/M regimens
TB Alliance Welcomes WHO Prequalification of Lupin’s Pretomanid Product
NEW YORK (September 12, 2025)—Lupin Limited, a leading pharmaceutical company headquartered in India, has been granted prequalification by the World
Bangladesh TB Leaders Build Momentum for Shorter, Safer Drug-Resistant Tuberculosis Treatment
Capacity building program in the Philippines empowers Bangladesh NTP managers to scale up BPaL and BPaL/M regimens MAKATI CITY, PHILIPPINES—PeerLINC